 |
Free monthly e-newsletter – Health Outcomes Communicator Great communication ideas for healthcare economists Healthcare Outcomes Communicator (HOC) is packed with information and ideas for health economists and outcomes researchers… especially about how you can more effectively communicate your work and its value to stakeholders within your organisation and outside it.
Why an e-newsletter for healthcare economists and outcomes researchers – and why now?
As regulatory barriers are placed higher, and cost and proof of efficacy issues assume ever greater importance in healthcare decision making, the health economists’ role is changing and expanding. You face pressures to persuade your colleagues and the wider world of clinicians, pharmacists, hospitals, government and private payers that what you’re doing not only has scientific rigour, but is innovative, creative, and effective. This educational challenge is paramount, because only when your work is understood and appreciated by your potential audiences can the information you generate achieve the impact it should. Healthcare Outcomes Communicator has been created to help you communicate the essence and the value of your work simply and effectively to all stakeholders in healthcare, thus engendering the respect you deserve.
So far we have covered:
- 2009 brings a move toward ending pharma freebies
- 3rd Annual ISMPP meeting
- 4th Annual World Health Care Congress
- 5th Annual World Health Care Congress
- Abstract submission deadlines (issues
7,8,9,10,11, 12,13,14,15,16,17,18,19,20,21,22,24,25,26,27,28,
29,31,32,33,34,35,36,37,38)
- Access to medicines: Ranking the social responsibility of pharmaceutical companies
- Alcohol and global warming
- AMWA Annual Conference 2007
- AMWA Annual Conference 2008
- A new way for pharmaceutical companies and prescribers to interact?
- Are drug appeals too chaotic?
- Arrival of ASHE signals growth of health economics in the US
- ASHE revisited
- Becoming accustomed to public speaking
- 'Big box' companies and public health
- Big Brother may be reading your emails
- Book review: Methods for the economic evaluation of health care programmes 3rd edition
- Book review: Prevention effectiveness 2nd edition
- Bridging cultural gaps
- Bringing healthcare to the worksite
- Calls for publishing negative data
- Canada Healthcare from paper to pixels
- Choosing a specific agency
- Clinical trials top ten mistakes in statistical analysis of clinical trials
- Commonwealth Fund survey finds more than 80% of respondents
want fundamental change in US healthcare
- Conquering chaos: six steps to an organised office
- Coping with information overload
- Copyright and plagiarism: be aware
- Dealing with the media – confidently
- Defining the healthcare debate in the US
- Direct-to-consumer advertising
- Drowning in email? Here are some life belts
- Drug approval agencies Australia
- Drug approval agencies US FDA and EMEA
- Drug makers gift disclosures: the ethics issue
- DSURs: simplifying periodic safety reporting
- Effective communication as a matter of fact
- Effective communication creating posters that get your message across
- Effective communication first make a connection
- Effective communication try to be yourself
- Efficient time management
- Essentials of foolproof proofreading
- Ethics in publishing: 1 Plagiarism
- Ethics in publishing: 2 Authorship
- Ethics in publishing: 3 Conflict of interest
- Feel the fear and speak anyway
- Finding those journals with a positive interest in health economics
- Firewalls revisited: they may not be a Bad Thing, after all
- Galbraith: keeping it simple
- Getting drugs accepted: who succeeds and why
- Getting the word out without giving away trade secrets
- Getting your message across in health economics
- Giving and taking feedback
- Healthcare blogs
- Health economists' broader role in lifestyles, demographics, and risk management
- Healthy scepticism about research
- HOC people Alan Bakst
- HOC people – David Nash
- HOC people – Dennis Gross
- HOC people – Diana Brixner
- HOC people – Patti Peeples
- HOC people – Ruth Whittington
- HOC people – Vittorio Maio
- HOC people – meet the team
- How health economists can develop a global perspective
- How sick are you? It depends what the definition of sick' is
- How to avoid getting kicked by the media donkey
- How to be a more effective public speaker
- How to counter the perception that health economics is a soft science
- How to hold on to your web visitors
- How to improve staff morale
- How to make the best use of graphics: Part 1 bar charts
- How to make the best use of graphics: Part 2 line graphs
- How to make the best use of graphics: Part 3 pie charts
- How to make the most of conferences
- How to present health economics to non-economists
- How to prove value as well as efficacy
- How to select a healthcare agency
- How to turn that mountain of must reading into a manageable molehill
- How to use visual images when explaining QALYs
- How to write a book review
- How to write a good sentence – length and rhythm
- Industry commentary (issues 14,15)
- Industry funding of medical education
- In praise of eloquence
- In-store health clinics: a new approach to primary care?
- Is big pharma becoming big biotech?
- Is big pharma becoming big biotech – re-visit?
- Is it time for a government-run national healthcare system in the US?
- Is the NHS on its last legs?
- ISPOR 9th Annual European meeting at Copenhagen
- ISPOR's 12th annual international meeting
- ISPOR 10th Annual European meeting in Dublin
- ISPOR 11th Annual European meeting in Athens
- It's not what you say, but how you say it
- ‘Junk Bond King’ melds economics and science in special one-day conference
- Launch of Greenflint
- Let's hear it for sound listening skills
- Letter to the editor
- Macro- and micro-editing
- Making adherence work
- Making sense of health economics
- Maintaining good relationships with your chosen agency
- Medical
writing: vigilance for ethics
- Medical tourism: way of the future or flight of fancy?
- Meeting the challenge of meetings
- Newt Gingrich: more transparency and technology needed
- Observational studies: answering real-life questions about healthcare practice
Part 1 What are observational studies?
Part 2 How do observational studies and randomised controlled trials differ?
Part 3 Conducting an observational study
Part 4 – Interpreting the results of observational studies
- Outsourcing clinical trials
- Overcoming writer's block
- Panel discussions
- Presenteeism and the impact of appropriate pharmaceutical treatment on workplace costs
- Preventing medication errors
- Prevention information on the Internet
- Profile: Health policy academics Jennifer Lofland and Laura Pizzi
- Profile: Madhusree Singh, health economist
- Pros and cons of direct-to-consumer advertising
- Regulating DTC ads
- Risk/benefit decisions
- Scientific conferences: time for rigorous appraisal
- Simplifying data
- Simplifying drug labels
- Social networking for patients
- Standards for pharmacoeconomic guidelines
- Talking risk:
how to communicate health outcomes to non-health economists
- Take a sensory break
- The future of healthcare economics innovation
- The Gunning Fog Index: a useful tool for targeting an article to an audience
- The importance of the economic value message
- The mean versus the gene
- The “other drug costs” – Part 1: non-adherence
- The pharmaceutical industry: good news not always well told
- The power of emotional intelligence
- The pros and cons of e-publishing
- The rewards of research
- Time for pharma industry bailout?
- Tips for communicating with email
- Tools of the trade: mastering the interview
- Top clichés of 2006
- Top ten health economic journals
- Tough choices about expensive drugs
- Training programmes for health economists
- Understanding study design in comparing drug studies
- Up against a firewall? How to breach the defences of marketing and sales
- Using euphemisms and jargon in health economics
- Using PowerPoint effectively
- Using PROs to support label claims
- Universal healthcare in the US?
- Value of drug innovation
- Watch your language (issues
1,2,3,4,5,6,7,9)
- What are journal editors looking for from health economists?
- What are the issues that keep you awake at night and what is Health Outcome Communicator 's prescription?
- What is an editorial?
- What is the value of outcomes research?
- W(h)ither the FDA?
- WHC and ISMMP congresses
- Why isn't e-prescribing adopted more widely?
- Why they rejected your manuscript
- Wiring healthcare
- You need to know the global issues in health economics
- You want money? Improve your chances of writing a winning grant proposal
|
|
|
|
Past issues
2009
 April issue 39
March issue 38
February issue 37
January issue 36
2008
December issue 35
November issue 34
October issue 33
September issue 32
August issue 31
July issue 30
June issue 29
May issue 28
April issue 27
March issue 26
February issue 25
January issue 24
2007
December issue 23
November issue 22
October issue 21
September issue 20
August issue 19
July issue 18
June issue 17
May issue 16
April issue 15
March issue 14
February issue 13
January issue 12
2006
December issue 11
November issue 10
October issue 9
September issue 8
August issue 7
July issue 6
June issue 5
May issue 4
April issue 3
March issue 2
February issue 1
HOC is delivered to a targeted audience once a month by subscription to join our
ever-growing mailing list, simply enter your email address below and select the Join button.
Content list
If you would like to receive previous issues in pdf
format please submit an
email request to duncan.dibble@rxcomms.com.
|
|
